Indications and uses
Helps prevent sunburn If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun.
Too Cool For School
- Manufacturer
- Too Cool For School USA, Inc | Hanbul Cosmetics Co., Ltd.
- Effective date
- 2015-07-31
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:43:27
Label at a glance#
ProductToo Cool For School DINOPLATZ La Ola Viento No.21
Active ingredientENSULIZOLE, OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE
Label structure10 sections
Dosage and administration
Apply liberally 15 minutes before sun exposure Use a water resistant sunscreen if swimming or sweating Reapply at least every 2 hours Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: – Limit time in the sun, especiall...
Storage and handling
Protect the product in this container from excessive heat and direct sunlight. You may report a serious adverse event from use of this product to: Too Cool For School USA INC. 181 North 11th Street #201 Brooklyn, NY 11211
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
OTC - PURPOSE SECTION
| Active ingredients | Purpose |
|---|---|
| Ensulizole 2.00% | Sunscreen |
| Octinoxate 2.00% | Sunscreen |
| Octocrylene 3.00% | Sunscreen |
| Titanium dioxide 9.69% | Sunscreen |
Uses
- Helps prevent sunburn
- If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.
Warnings
- For external use only.
OTC - DO NOT USE SECTION
- Do not use on damaged or broken skin.
OTC - WHEN USING SECTION
- When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
- Stop use and ask a doctor if rash occurs.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Apply liberally 15 minutes before sun exposure
- Use a water resistant sunscreen if swimming or sweating
- Reapply at least every 2 hours
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
- Limit time in the sun, especially from 10 a.m.-2 p.m.
- Wear long-sleeved shirts, pants, hats and sunglasses
- Children under 6 months : Ask a doctor
Other information
- Protect the product in this container from excessive heat and direct sunlight.
- You may report a serious adverse event from use of this product to: Too Cool For School USA INC. 181 North 11th Street #201 Brooklyn, NY 11211
Inactive Ingredients
SEA WATER/EAU DE MER, TRIETHYLHEXANOIN, C12-15 ALKYL BENZOATE, GLYCERIN, DIMETHICONE, OZOKERITE, CERESIN, BUTYLENE GLYCOL, NIACINAMIDE, TRIETHANOLAMINE, SUCROSE TETRASTEARATE TRIACETATE, POLYMETHYL METHACRYLATE, HYDROGENATED POLYISOBUTENE, PHENYL TRIMETHICONE, SODIUM CHLORIDE, CETYL PEG/PPG-10/1 DIMETHICONE, SYNTHETIC FLUORPHLOGOPITE, MICROCRYSTALLINE WAX/ CIRE MICROCRISTALLINE, SORBITAN OLIVATE, SQUALANE, ETHYL HEXANEDIOL, SILICA, METHICONE, GLYCERYL CAPRYLATE, MAGNESIUM STEARATE, SORBITAN SESQUIOLEATE, FRAGRANCE/PARFUM, TRIETHOXYCAPRYLYLSILANE, ALUMINUM HYDROXIDE, ADENOSINE, HYDROLYZED COLLAGEN, ARTEMIA EXTRACT, UNDARIA PINNATIFIDA EXTRACT, LAMINARIA DIGITATA EXTRACT, IRON OXIDES (CI 77491, CI 77492, CI 77499)
SPL UNCLASSIFIED SECTION
Dist. by ©Too Cool For School USA Inc. Brooklyn, NY 11211
PRINCIPAL DISPLAY PANEL - #21 Kit Carton
Dinoplatz La Ola Viento #21
all-in-one make up kit with Broad Spectrum SPF 50 Sunscreen
_BB foundation 13g (0.45 oz)
_Brightener 1g (0.03 oz)
_Concealer 1g (0.03 oz)
_Cheek 1g (0.03 oz)
PRINCIPAL DISPLAY PANEL - #23 Kit Carton
Dinoplatz La Ola Noche #23
all-in-one make up kit with Broad Spectrum SPF 50 Sunscreen
_BB foundation 13g (0.45 oz)
_Brightener 1g (0.03 oz)
_Concealer 1g (0.03 oz)
_Cheek 1g (0.03 oz)
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d676a241-be05-4740-b3ee-1a5f2ed422d2 | Product name | 4 | 20180615 |
| dd8bd48f-20d6-43c7-b471-3ae872868afa | Product name | 3 | 20180125 |
| d41954ff-bc63-4b2c-aba0-9146707659d7 | Product name | 2 | 20151117 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69926-008-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2167-f424-e053-dadaa90a57ce | Too Cool For School DINOPLATZ La Ola Viento |
| 69926-009-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2167-f424-e053-dadaa90a57ce | Too Cool For School DINOPLATZ La Ola Viento |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69926-008-01 | Too Cool For School DINOPLATZ La Ola Viento No.21 | 1 in 1 CARTON | KIT | 1 | 1 | |
| 69926-009-01 | Too Cool For School DINOPLATZ La Ola Noche No.23 | 1 in 1 CARTON | KIT | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69926-008 | TOO COOL FOR SCHOOL DINOPLATZ LA OLA VIENTO NO.21 (ENSULIZOLE, OCTINOXATE, OCTOCRYLENE, AND TITANIUM DIOXIDE) KIT TOO COOL FOR SCHOOL DINOPLATZ LA OLA NOCHE NO.23 (ENSULIZOLE, OCTINOXATE, OCTOCRYLENE, AND TITANIUM DIOXIDE) KIT [TOO COOL FOR SCHOOL USA, INC] | 1 | Legacy NDC, 1 package rows | 20150901_9cbda3f3-099f-4c89-961f-508568962b5c.zip |
| 69926-009 | TOO COOL FOR SCHOOL DINOPLATZ LA OLA VIENTO NO.21 (ENSULIZOLE, OCTINOXATE, OCTOCRYLENE, AND TITANIUM DIOXIDE) KIT TOO COOL FOR SCHOOL DINOPLATZ LA OLA NOCHE NO.23 (ENSULIZOLE, OCTINOXATE, OCTOCRYLENE, AND TITANIUM DIOXIDE) KIT [TOO COOL FOR SCHOOL USA, INC] | 1 | Legacy NDC, 1 package rows | 20150901_9cbda3f3-099f-4c89-961f-508568962b5c.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ENSULIZOLE | ACTIVE INGREDIENT | 9YQ9DI1W42 | 1 | |
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| OCTOCRYLENE | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| ENSULIZOLE | ACTIVE MOIETY | 9YQ9DI1W42 | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| OCTOCRYLENE | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| ADENOSINE | INACTIVE INGREDIENT | K72T3FS567 | 1 | |
| ALKYL (C12-15) BENZOATE | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| ALUMINUM HYDROXIDE | INACTIVE INGREDIENT | 5QB0T2IUN0 | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| CERESIN | INACTIVE INGREDIENT | Q1LS2UJO3A | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| ETHOHEXADIOL | INACTIVE INGREDIENT | M9JGK7U88V | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERYL CAPRYLATE | INACTIVE INGREDIENT | TM2TZD4G4A | 1 | |
| LAMINARIA DIGITATA | INACTIVE INGREDIENT | 15E7C67EE8 | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| MICROCRYSTALLINE WAX | INACTIVE INGREDIENT | XOF597Q3KY | 1 | |
| NIACINAMIDE | INACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| PHENYL TRIMETHICONE | INACTIVE INGREDIENT | DR0K5NOJ4R | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| SORBITAN OLIVATE | INACTIVE INGREDIENT | MDL271E3GR | 1 | |
| SORBITAN SESQUIOLEATE | INACTIVE INGREDIENT | 0W8RRI5W5A | 1 | |
| SQUALANE | INACTIVE INGREDIENT | GW89575KF9 | 1 | |
| SUCROSE TETRASTEARATE TRIACETATE | INACTIVE INGREDIENT | 1K7LBQ045N | 1 | |
| TRIETHOXYCAPRYLYLSILANE | INACTIVE INGREDIENT | LDC331P08E | 1 | |
| TRIETHYLHEXANOIN | INACTIVE INGREDIENT | 7K3W1BIU6K | 1 | |
| TROLAMINE | INACTIVE INGREDIENT | 9O3K93S3TK | 1 | |
| UNDARIA PINNATIFIDA | INACTIVE INGREDIENT | ICV1OK7M1S | 1 |
Products#
Every source-derived product name is available through these pages.
- Too Cool For School DINOPLATZ La Ola Viento No.21
- ENSULIZOLE, OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE
- BB Foundation
- ENSULIZOLE
- OCTINOXATE
- OCTOCRYLENE
- TITANIUM DIOXIDE
- SODIUM CHLORIDE
- TRIETHYLHEXANOIN
- ALKYL (C12-15) BENZOATE
- GLYCERIN
- DIMETHICONE
- CERESIN
- BUTYLENE GLYCOL
- NIACINAMIDE
- TROLAMINE
- SUCROSE TETRASTEARATE TRIACETATE
- PHENYL TRIMETHICONE
- MICROCRYSTALLINE WAX
- SORBITAN OLIVATE
- SQUALANE
- ETHOHEXADIOL
- SILICON DIOXIDE
- GLYCERYL CAPRYLATE
- MAGNESIUM STEARATE
- SORBITAN SESQUIOLEATE
- TRIETHOXYCAPRYLYLSILANE
- ALUMINUM HYDROXIDE
- ADENOSINE
- UNDARIA PINNATIFIDA
- LAMINARIA DIGITATA
- FERRIC OXIDE RED
- Concealer
- CETEARYL ETHYLHEXANOATE
- MICA
- DIISOSTEARYL MALATE
- ALUMINUM STARCH OCTENYLSUCCINATE
- YELLOW WAX
- HYDROGENATED CASTOR OIL
- .ALPHA.-TOCOPHEROL ACETATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 69926-008 | 69926-008-01 |
| 69926-009 | 69926-009-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | SOLUTION / TOPICAL | NA | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 2 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 47 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SUSPENSION / INTRA-ARTICULAR | 45 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, COATED / ORAL | 0.12 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRATHECAL | 131 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SUSPENSION / SUBCUTANEOUS | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 52800 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, EXTENDED RELEASE / TRANSDERMAL | 616 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SUPPOSITORY / RECTAL | 14 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 336 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CREAM / TOPICAL | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRASYNOVIAL | 4 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | SOLUTION / NASAL | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | IMPLANT / SUBCUTANEOUS | 77 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRACARDIAC | 70 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | PASTE / DENTAL | 34 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SOLUTION / ORAL | 1.8 mg/120ml | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / TOPICAL | 0.32 %w/v | ||
| NIACINAMIDE | NIACINAMIDE | 25X51I8RD4 | INJECTION / INTRAMUSCULAR | 2.5 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INFILTRATION | 3535 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER / TOPICAL | NA | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SYRUP / ORAL | 40 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | LOTION / TOPICAL | 360 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SPRAY / NASAL | 30 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | SPONGE / TOPICAL | 11 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / TOPICAL | 0.23 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | CAPSULE, EXTENDED RELEASE / ORAL | 41 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / AURICULAR (OTIC) | 18 mg | ||
| SQUALANE | SQUALANE | GW89575KF9 | SOLUTION / TOPICAL | 1 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / NASAL | 20 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / ORAL | 148 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / ORAL | 420 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, CHEWABLE / ORAL | 20 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| ALUMINUM HYDROXIDE | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | CREAM / TOPICAL | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / ORAL | 1126 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | AEROSOL, FOAM / TOPICAL | 2.6 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / DENTAL | 19 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| ALUMINUM HYDROXIDE | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | CAPSULE / ORAL | NA | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE / ORAL | 1190 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, DELAYED RELEASE / ORAL | 14 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | WAFER / ORAL | 66 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER / ORAL | 25 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SOLUTION / ORAL | 380 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b007c7aa-a57c-443a-b556-9252181fa7ca | 9cbda3f3-099f-4c89-961f-508568962b5c | 2015-07-31 | Warnings | b007c7aa-a57c-443a-b556-9252181fa7ca 9cbda3f3-099f-4c89-961f-508568962b5c |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.